Bringing Surgical Procedures Into the Office

Release Date:  January 1, 2013
Expiration Date: December 31, 2013

Estimated time of Completion: 35 minutes

Description

This course provides a basic introduction to the creation of an office-based surgical practice with an emphasis on guidelines for patient safety and regulatory issues, recommendations for transitioning from the hospital or ambulatory surgery center to the office, and examples of appropriate procedures to be considered for performance in an office setting.

Learning Objectives

1. List patient co-morbidities that are contraindications to office surgery.
2. List qualities of surgical procedures that make them appropriate for the office setting.
3. List the Levels of Office-Based Surgery.
4. List important features of an office-based surgical practice to promote patient safety.
5. Describe the types of documentation necessary to maintain an office-based surgical practice.
6. List the various agencies and associations that have published guidelines concerning office-based surgery

Target Audience

Educational activities are developed to meet the needs of surgical gynecologists in practice and in training, as well as, other allied healthcare professionals in the field of gynecology.

The AAGL is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The AAGL designates this live activity for a maximum of .50 Hours AMA PRA Category 1 Credit(s)^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Professional Development Committee

Faculty
Micah Harris MD, FACOG
Director, OB/Gyn Consultants and Women’s Health Research
Phoenix, AZ

Valued assistance from
Ted L. Anderson, MD, PhD, FACOG, FACS
Director, Division of Gynecology
Director, Minimally Invasive Gynecologic Surgery
Vanderbilt University Medical Center, Nashville, TN

Content Reviewer
Franklin D. Loffer, MD

Ted L. Anderson, MD, PhD, FACOG, FACS*
Art Arellano*
Linda Bradley, MD
Consultant: Bayer Healthcare Corp., Conceptus Incorporated, Ferring Pharmaceuticals
Speakers Bureau: Bayer Healthcare Corp., Conceptus Incorporated,   Ferring Pharmaceuticals
Grant/Research: Elsevier
Micah Harris, MD, FACOG
Speakers Bureau: HALT Medical; Hologic, Inc.
Clinical Investigator: Abbott Pharmaceuticals, HALT Medical, Teva Pharmaceuticals, Warner-Chillcott
Franklin D. Loffer, MD*
Linda Michels*

Asterisk (*) denotes no financial relationships to disclose.

The AAGL acknowledges that it has received an educational grant from Hologic, Inc.

This CME activity was produced by AAGL and the information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by AAGL. In no event will AAGL be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Click here to view AAGL's Policy on Enduring Materials